We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Spinal Cord Stimulator Helps Treat Chronic Pain

By HospiMedica International staff writers
Posted on 12 Feb 2019
A new spinal cord stimulator (SCS) system combines paraesthesia and sub-perception therapy to treat chronic and debilitating pain.

The Boston Scientific (Natick, MA, USA) Spectra WaveWriter is an implanted SCS system designed to help in the management of chronic obdurate pain of the trunk and/or limbs, including unilateral or bilateral pain associated with failed back surgery syndrome, intractable lower back and leg pain, complex regional pain syndrome (CRPS), radicular pain syndrome, and radiculopathies resulting in secondary pain, such as failed back surgery, a herniated disc, degenerative disc disease (DDD), and others.

The two main components of the system are the signal generator, implanted under the skin, which sends electrical stimulation signals to the spinal cord through an insulated lead wire, and a hand-held remote control that allows the patient to control it. More...
The signal generator is programmed to produce electrical signals that can block pain signals traveling to the patient's brain through a combination of novel sub-perception algorithms and waveform automation. Studies have shown an improvement in pain of 29.2-100% for CRPS patients, and 37-77% for those with back and leg pain due to surgery-associated conditions.

“We are introducing industry-leading SCS technology to help provide patients with lasting relief from chronic pain,” said Maulik Nanavaty, president and senior vice president of neuromodulation at Boston Scientific. “We are committed to investing in research and expanding treatment options for chronic pain by identifying new, non-opioid solutions for the millions of people suffering from this debilitating condition.”

“Pain is very personal, and everyone experiences it differently. Pain also changes over time, which for chronic pain patients means that their bodies may become accustomed to treatment and its effectiveness declines,” said Vivek Mehta, a consultant in pain medicine at Queen Mary, University of London (QMUL; United Kingdom). “The Spectra WaveWriter SCS system allows us to combine multiple treatment options in one single device, intended to give patients truly personalized therapy that evolves just as their pain does to provide lasting relief.”

SCS works by sending electrical impulses to the spinal cord, masking the pain signals travelling to the brain. These electrical impulses can vary in frequency, pulse width, and amplitude, providing pain relief with a light tingling sensation known as paraesthesia-based therapy or with sub-perception therapy that works without sensation.


Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Preoperative Skin Preparation
BD ChloraPrep
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image: The findings suggest that hematopoietic cell transplantation may benefit patients with Shwachman-Diamond syndrome soon after high-risk features are detected, before advanced malignancy develops. (Image Credit: Shutterstock)

Early Stem Cell Transplantation May Improve Survival in Rare Inherited Bone Marrow Disorder

Shwachman-Diamond syndrome (SDS) is a rare inherited bone marrow disorder that can progress to severe hematologic disease. More than 90% of affected children survive beyond age 20, but fewer than 30% live... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.